Eysuvis®

Loteprednol Etabonate 0.25%
ophthalmic suspension
Steroid
[ Corticosteroid]
Indication

Indication

Short-term treatment of dry eye disease
Mechanism of Action

Mechanism of Action

Inhibits leukocyte migration, capillary dilation, fibroblast proliferation
Common quantities available

Available Quantities

8.3 ml
Dosage

Dosage/Instructions

1 or 2 drops 4 times/day, up to 2 weeks
Pregnancy & Nursing Data

Pregnancy & Nursing

Teratogenic in rabbits at clinical doses; no human data
Pediatric Use

Pediatric Use

≥18 years
Warnings Tab

Contraindications, side effects, etc.

Contraindications: Hypersensitivity to loteprednol etabonate or related corticosteroids. Contraindicated in patients with fungal or viral eye infections. Warnings: Loteprednol etabonate is a corticosteroid and may increase the risk of elevated intraocular pressure, cataracts, and secondary eye infections. It should be used cautiously and under supervision. Common Side Effects: Common side effects include eye irritation, burning, and stinging.